Novel conditionally active T cell engagers sourced from proprietary BiTAC® platform are at the basis of advanced partnering initiatives and development activities ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - ...

Biotechnology investors often focus on clinical milestones, regulatory approvals, and commercial launches. Yet in antibody ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

AI architect and supply chain expert Vineel Mouli Natakam is transforming pharmaceutical logistics with intelligent, ...

Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...

GEA has moved its Application and Technology Center (ATC) for New Food and biotechnology from Hildesheim to Sarstedt in Lower Saxony, Germany, investing €4 ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-per ...